Iradimed Corp (IRMD)
21.21 x 2 69.99 x 3
Pre-market by (Cboe BZX)
53.02 -0.30 (-0.56%) 04/28/25 [NASDAQ]
21.21 x 2 69.99 x 3
Pre-market 53.02 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 19,234 | 17,193 | 12,829 | 9,326 | 1,369 |
Depreciation Amortization | 818 | 765 | 671 | 1,407 | 1,339 |
Income taxes - deferred | -698 | -1,172 | 57 | 524 | 390 |
Accounts receivable | 1,762 | 842 | -8,241 | -576 | 2,691 |
Accounts payable and accrued liabilities | -862 | -216 | 1,125 | 30 | -404 |
Other Working Capital | 3,749 | -5,910 | -5,056 | -1,576 | -1,172 |
Other Operating Activity | 1,621 | 1,964 | 8,659 | 2,124 | 1,605 |
Operating Cash Flow | $25,625 | $13,465 | $10,043 | $11,258 | $5,818 |
Cash Flows From Investing Activities | |||||
Change In Deposits | N/A | N/A | 500 | 1,390 | 884 |
PPE Investments | -8,817 | -8,007 | -1,875 | -742 | -637 |
Investing Cash Flow | $-8,817 | $-8,007 | $-1,375 | $648 | $247 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 30 | 177 | 147 | 623 | 1,730 |
Dividend Paid | -13,677 | -13,223 | -12,559 | N/A | N/A |
Other Financing Activity | -688 | -610 | -294 | -599 | -1,208 |
Financing Cash Flow | $-14,336 | $-13,657 | $-12,706 | $24 | $523 |
Beginning Cash Position | 49,762 | 57,961 | 62,000 | 50,069 | 43,482 |
End Cash Position | 52,234 | 49,762 | 57,961 | 62,000 | 50,069 |
Net Cash Flow | $2,472 | $-8,199 | $-4,039 | $11,931 | $6,587 |
Free Cash Flow | |||||
Operating Cash Flow | 25,625 | 13,465 | 10,043 | 11,258 | 5,818 |
Capital Expenditure | -8,817 | -8,007 | -1,875 | -742 | -637 |
Free Cash Flow | 16,808 | 5,458 | 8,168 | 10,516 | 5,181 |